STEM INC (STEM)       13.69  +0.42 (+3.17%)

13.69  +0.42 (+3.17%)

US85859N1028 - Common Stock - Premarket: 13.59 -0.1 (-0.73%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to STEM. STEM was compared to 86 industry peers in the Electrical Equipment industry. STEM scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. STEM is valued quite expensive, but it does show an excellent growth.




Profitability

Profitability Rating

3

STEM has a Return On Assets of -8.67%. This is comparable to the industry average of -11.58%.
STEM has a Profit Margin of -47.19%. This is comparable to the industry average of -25.08%.

STEM has a Piotroski-F score of 4.00. This indicates an average health and profitability for STEM.
The profitability ratios for STEM are negative, so there is not much use analyzing them.
VS Industry

ROA (-8.67%) VS Industry: 55% outperformed.

-190.82
43.03

Profit Margin (-47.19%) VS Industry: 41% outperformed.

-37,039.07
33.94

Valuation

Valuation Rating

1

With a price book ratio of 3.67, STEM is valued correctly.
The Price/Earnings Ratio is negative for STEM. In the last year negative earnings were reported.

Also next year STEM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
When comparing the price book ratio of STEM to the average industry price book ratio of 2.70, STEM is valued more expensive than its industry peers.
VS Industry

Price/Book (3.67) VS Industry: 40% outperformed.

2,931.82
0.16

Growth

Growth Rating

7

STEM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.86%, which is quite impressive.
Looking at the last year, STEM shows a very strong growth in Revenue. The Revenue has grown by 339.95%.

The Revenue is expected to grow by 55.26% on average over the next 5 years. This is a very strong growth
STEM is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 9.95% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 84.86% 21.03% 24.03% 22.23% 9.95%
RevenueN/A N/A 339.95% 163.78% 104.29% 79.06% 55.26%

Health

Health Rating

4

STEM has a Current Ratio of 2.23. This indicates that STEM is financially healthy and has no problem in meeting its short term obligations.
STEM has a Quick Ratio of 2.11. This indicates that STEM is financially healthy and has no problem in meeting its short term obligations.
STEM is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.48.
The Current Ratio is in line with the industry averages, which is at 2.25.

The Piotroski-F score of STEM is 4.00. This is a neutral score and indicates average health and profitability for STEM.
STEM has one of the worst Debt to Equity ratios in its industry. 83% of its industry peers require less debt for financing their operations.
Based on the Altman-Z score of 1.06, we must say that STEM is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.22, STEM is in worse financial health than its industry peers.
VS Industry

Debt/Equity (0.78) VS Industry: 17% outperformed.

10.41
0.00

Quick Ratio (2.11) VS Industry: 64% outperformed.

0.36
28.86

Current Ratio (2.23) VS Industry: 47% outperformed.

0.71
28.86

Altman-Z (1.06) VS Industry: 34% outperformed.

-21.85
3,309.37

Dividend

Dividend Rating

0

No dividends for STEM!.

STEM Daily chart

STEM INC13.69

NYSE:STEM (11/25/2022, 6:28:47 PM)+0.42 (+3.17%)

Premarket: 13.59 -0.1 (-0.73%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Capital Goods
GICS Industry Electrical Equipment
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-22 2023-02-22
Ins Owners 1.58% Inst Owners 52.44%
Market Cap 2.11B Analysts 82.5
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 8.12 P/B 3.67
EV/EBITDA -24.17
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y 84.86% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 80.53%
EPS Next Y 21.03% EPS Next 2Y 24.03%
EPS Next 3Y 22.23% EPS Next 5Y 9.95%
Revenue growth 1Y 339.95% Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q 149.8%
Revenue Next Year 163.78% Revenue Next 2Y 104.29%
Revenue Next 3Y 79.06% Revenue Next 5Y 55.26%
Health
Current Ratio 2.23 Quick Ratio 2.11
Altman-Z 1.06 F-Score 4
Debt/Equity 0.78 WACC 11.84%
ROIC/WACC N/A
Profitability
ROA -8.67% ROE N/A
ROICexgc N/A ROIC N/A
PM -47.19% OM -49%
Asset Turnover 0.18

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA